I began my career in 2019, conducting research on immune signaling pathways involved
in neuroinflammation and cancer pyroptosis. This foundational work sparked a deep
interest in the role of the immune system across various disease contexts.
In 2024, I transitioned to a clinical focus by joining in this Mycobacteria/Nocardia
Laboratory, where I utilize advanced molecular diagnostic techniques to enhance the
detection and management of pathogens such as Mycobacterium, Nocardia, and aerobic
actinomycetes-orgasnisms that significantly impact cell-mediated immunity. I am committed
to integrating molecular tools into patient care, particularly for antimicrobial resistance
surveillance, to enable timely and precise therapeutic decisions. By bridging immune
biology with pathogen genomics, my goal is to advance the understanding of host-pathogen
interactions and resistance mechanisms, ultimately advancing both clinical practice
and translational research.